期刊文献+

2型糖尿病肥胖与非肥胖血液流变学和血脂变化 被引量:1

原文传递
导出
摘要 2型糠尿病77例,分为肥胖与非肥胖组,测定空腹胰岛素,血流变学等检查。结果肥胖组胰岛素敏感性指数低于非肥胖组,空腹血胰岛素、血尿酸高于非肥胖组,肥胖的糖尿病患者,其血脂及血液流变学变化,TG及TC,均与非肥胖者比较有显著差异,但2组的APOA、APOB、LP(a)、LDL无显著差异。其全血粘度高切、低切,血浆粘度均高于肥胖者,而红细胞压积高于非肥胖者,差异显著。结论肥胖的2型糖尿病患者存在明显的胰岛素敏感性减低、高胰岛素血症、高尿酸血症、高粘血症及脂代谢紊乱,提示改善肥胖本身,降低血粘度以及针对脂毒性的治疗在2型糖尿病综合治疗中的重要地位。
出处 《实用糖尿病杂志》 2005年第6期25-26,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献6

二级参考文献15

  • 1林其燧 文庆成.临床化学诊断方法大全[M].北京:北京大学出版社,1990.488.
  • 2潘其心.载脂蛋白与冠心病[J].心血管病学进展,1988,9(4):15-15.
  • 3[1]Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in woman. Ann Intern Med 1995, 122:481~486.
  • 4[2]Boden G. Role of fatty aids in the pathogenesis of insulin resistance and NIDDM.Diabetes 1997,46:3~10.
  • 5[3]Hota misligil - GS, Budavari A, Murray D, et al. Reduce tyrosine kinase activity of the insulin receptor in obesity - diabetes. Central role of tumor necrosis factor α. J Clin Invest 1994, 94:1543~ 1549.
  • 6[4]Wang CN, O' Brindley L, Brindley DN. Effect of cell permeable ceramides and tumor necrosis factor α on insulin signaling and glucose uptake in 373 - LI adipocytes. Diabetes 1998,47:24~31.
  • 7[5]Kersten S, Desvergne B, Wahli W. Role of PPARs in health and disease. Nature 2000, 405: 421~ 424.
  • 8Choi CS,Lee FN,Youn JH.Free fatty acids induce peripheral insulin resistance without increasing muscle hexosamine pathway product levels in rats[].Diabetes.2001
  • 9Storlien LH,Oakes ND,Pan DA,et al.Syndrome of insulin resistance in the rat.Inducement by diet and amelioration with benfluorex[].Diabetes.1993
  • 10Battilana P,Seematter G,Schneiter P,et al.Effects of free fatty acids on insulin sensitivity and hemodynamics during mental stress[].The Journal of Clinical Endocrinology.2001

共引文献99

同被引文献38

  • 1Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res Clin Pract,2010,87:4-14.
  • 2Unwin N,Gan D,Whiting D.The IDF diabetes atlas:providing evidence,raising awareness and promoting action.Diabetes Res Clin Pract,2010,87:2-3.
  • 3World Health Organization and C.D.Bode,Media Centre-Fact Sheets,Diabetes,2011.http://www.who.int/mediacentre/factsheets/fs312/en/index.
  • 4Guilherme A,Virbasius J,Vishwajeet P,et al.Adipocyte dysfunction linking obesity to insulin resistance and type 2 diabetes.Nat Rev Mol Cell Biol,2008,9:367-377.
  • 5Yoon KH,Lee JH,Kim JW,et al.Epidemic obesity and type 2 diabetes in Asia.Lancet,2006,368:1681-1688.
  • 6Bell GI,Polonsky KS.Diabetes mellitus and genetically programmed defects in beta-cell function.Nature,2001,414:788-791.
  • 7Butler AE,Janson J,Bonner-Weir S,et al.Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.Diabetes,2003,52:102-110.
  • 8Tabak AG,Jokela M,Akbaraly TN,et al.Trajectories of glycemia,insulin sensitivity and insulin secretion preceeding the diagnosis of type 2 diabetes:the whitehall II study.Lancet,2009,373:2215-2221.
  • 9Prentki M,Nolan CJ.Islet beta cell failure in type 2 diabetes.J Clin Invest,2006,116:1802-1812.
  • 10Dentin R,Benhamed F,Halnauh I,et al.Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.Diabetes,2006,55:2159-2170.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部